FDA Gives Approval To Blood Cancer Drug Empliciti

The FDA has granted approval to the use of the drug Empliciti in combination with two other drugs for treating patients with multiple myeloma. The drug Empliciti is the second FDA-approved monoclonal antibody used for multiple myeloma treatments.